• Our Experience

Gastroenterology

• A Phase II randomized, double-blind, placebo-controlled, multi-center study of an oral drug in patients with chronic constipation

• A Phase II randomized, double-blind, placebo-controlled, multi-center study of an oral drug in patients with irritable bowel syndrome with constipation